Vancomycin Injectable Drug Recalled Due to Lack of Sterility Assurance
Apollo Care, LLC is recalling VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection due to lack of assurance of sterility. The recall affects 1,622 bags distributed in Missouri.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable drug product with a potential sterility issue. No reported illnesses or injuries are mentioned in the source, placing this at the High level per the rubric criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Apollo Care, LLC is recalling VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, NDC 71170-254-25. The recall was issued due to a lack of assurance of sterility in the product.
The affected product includes 1,622 bags with the following lot numbers and expiration dates: Lot AC-016641 (Exp. 06/03/2023) and Lot AC-016653 (Exp. 07/26/2023). Distribution was limited to Missouri.
Healthcare providers and patients who have this product should discontinue use and contact Apollo Care, LLC at 3801 Mojave Ct., Suite 101, Columbia, MO 65202 for instructions on how to return the product. Patients should consult with their healthcare provider regarding appropriate alternative treatment.
The recalled product
- Product
- VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-254-25
- Manufacturer
- Apollo Care, LLC
- Category
- Drug
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: AC-016641
- Exp. Date 06/03/2023
- AC-016653 Exp. Date 07/26/2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27